67.78
price down icon6.00%   -4.33
pre-market  Pre-market:  67.26   -0.52   -0.77%
loading
Genedx Holdings Corp stock is traded at $67.78, with a volume of 960.90K. It is down -6.00% in the last 24 hours and down -25.55% over the past month. GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.
See More
Previous Close:
$72.11
Open:
$72.11
24h Volume:
960.90K
Relative Volume:
0.80
Market Cap:
$1.93B
Revenue:
$267.23M
Net Income/Loss:
$-83.50M
P/E Ratio:
-21.79
EPS:
-3.11
Net Cash Flow:
$-59.99M
1W Performance:
+14.01%
1M Performance:
-25.55%
6M Performance:
-5.95%
1Y Performance:
+226.65%
1-Day Range:
Value
$67.26
$73.57
1-Week Range:
Value
$58.28
$73.57
52-Week Range:
Value
$19.16
$117.75

Genedx Holdings Corp Stock (WGS) Company Profile

Name
Name
Genedx Holdings Corp
Name
Phone
888-729-1206
Name
Address
333 LUDLOW STREET, STAMFORD
Name
Employee
1,000
Name
Twitter
Name
Next Earnings Date
2025-02-18
Name
Latest SEC Filings
Name
WGS's Discussions on Twitter

Compare WGS with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Diagnostics & Research icon
WGS
Genedx Holdings Corp
67.78 1.70B 267.23M -83.50M -59.99M -3.11
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
398.28 153.28B 42.90B 6.52B 6.72B 17.05
Diagnostics & Research icon
DHR
Danaher Corp
186.81 134.42B 23.82B 3.77B 4.90B 5.15
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
500.87 40.97B 3.93B 894.97M 837.70M 10.82
Diagnostics & Research icon
A
Agilent Technologies Inc
108.91 31.79B 6.53B 1.26B 1.31B 4.35
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
137.29 24.53B 15.50B 1.33B 2.16B 7.34

Genedx Holdings Corp Stock (WGS) Upgrades & Downgrades

Date Action Analyst Rating Change
May-15-25 Initiated Guggenheim Buy
May-09-25 Upgrade Jefferies Hold → Buy
Aug-28-24 Initiated Wells Fargo Equal Weight
Jul-10-24 Initiated Craig Hallum Buy
Jun-03-24 Resumed Jefferies Hold

Genedx Holdings Corp Stock (WGS) Latest News

pulisher
May 20, 2025

GeneDx: Strong Fundamentals Intact As Market Misreads Test Volume Dip - Seeking Alpha

May 20, 2025
pulisher
May 16, 2025

GeneDx Holdings Corp (WGS) Shares Up 6.43% on May 16 - GuruFocus

May 16, 2025
pulisher
May 16, 2025

How the (WGS) price action is used to our Advantage - news.stocktradersdaily.com

May 16, 2025
pulisher
May 15, 2025

GeneDx (WGS) Receives Positive Outlook from Guggenheim with Buy Rating | WGS Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Guggenheim Initiates GeneDx Holdings at Buy With $88 Price Target - marketscreener.com

May 15, 2025
pulisher
May 14, 2025

GeneDx shares tumble 40% after InvestingPro's overvaluation alert By Investing.com - Investing.com South Africa

May 14, 2025
pulisher
May 14, 2025

GeneDx shares tumble 40% after InvestingPro’s overvaluation alert By Investing.com - Investing.com Nigeria

May 14, 2025
pulisher
May 14, 2025

GeneDx: Time To Buy The Dip (NASDAQ:WGS) - Seeking Alpha

May 14, 2025
pulisher
May 14, 2025

GeneDx plunges despite Q1 beat and guidance raise - MSN

May 14, 2025
pulisher
May 13, 2025

GeneDx Holdings stock trades higher as upgraded at Jefferies - MSN

May 13, 2025
pulisher
May 12, 2025

WGS: Key Meeting Announcement by BTIG in San Francisco | WGS Sto - GuruFocus

May 12, 2025
pulisher
May 12, 2025

GeneDx upgraded to Buy from Hold on growth outlook - MSN

May 12, 2025
pulisher
May 09, 2025

GeneDx Shares Rise After Ratings Upgrade From Jefferies - marketscreener.com

May 09, 2025
pulisher
May 09, 2025

GeneDx Holdings (WGS) Upgraded by Jefferies on Growth Prospects - GuruFocus

May 09, 2025
pulisher
May 09, 2025

GeneDx (WGS) Upgraded by Jefferies Amid Growth Prospects - GuruFocus

May 09, 2025
pulisher
May 09, 2025

GeneDx stock upgraded at Jefferies on outlook (WGS:NASDAQ) - Seeking Alpha

May 09, 2025
pulisher
May 09, 2025

Analyst Expectations For GeneDx Holdings's Future - Benzinga

May 09, 2025
pulisher
May 09, 2025

This National Vision Holdings Analyst Turns Bullish; Here Are Top 3 Upgrades For Friday - Benzinga

May 09, 2025
pulisher
May 09, 2025

Jefferies Upgrades GeneDx Holdings (WGS) - Nasdaq

May 09, 2025
pulisher
May 09, 2025

Jefferies Upgrades GeneDx to Buy From Hold, $80 Price Target - marketscreener.com

May 09, 2025
pulisher
May 09, 2025

GeneDx upgraded to Buy from Hold at Jefferies - TipRanks

May 09, 2025
pulisher
May 08, 2025

GeneDx completes acquisition of Fabric Genomics - Yahoo Finance

May 08, 2025
pulisher
May 07, 2025

GeneDx Holdings Corp. completed the acquisition of Fabric Genomics, Inc. - marketscreener.com

May 07, 2025
pulisher
May 07, 2025

GeneDx Holdings Becomes Oversold (WGS) - Nasdaq

May 07, 2025
pulisher
May 07, 2025

GeneDx Announces Completion of Fabric Genomics Acquisition - Business Wire

May 07, 2025
pulisher
May 06, 2025

Envestnet Asset Management Inc. Purchases New Shares in GeneDx Holdings Corp. (NASDAQ:WGS) - Defense World

May 06, 2025
pulisher
May 06, 2025

Where are the Opportunities in (WGS) - news.stocktradersdaily.com

May 06, 2025
pulisher
May 05, 2025

Best Momentum Stocks to Buy for May 5th - The Globe and Mail

May 05, 2025
pulisher
May 05, 2025

Best Momentum Stocks To Buy For May 5th - Barchart.com

May 05, 2025
pulisher
May 05, 2025

New Strong Buy Stocks for May 5th - Yahoo Finance

May 05, 2025
pulisher
May 02, 2025

Why Investors Were Avoiding GeneDx Holdings Stock This Week - AOL.com

May 02, 2025
pulisher
May 02, 2025

Stamford genetic-testing firm GeneDx still searching for tenants to sublet part of HQ, shuttered CT lab spaces - Hartford Business Journal

May 02, 2025
pulisher
May 02, 2025

With A 26% Price Drop For GeneDx Holdings Corp. (NASDAQ:WGS) You'll Still Get What You Pay For - simplywall.st

May 02, 2025
pulisher
May 02, 2025

GENEDX HOLDINGS (WGS) Upgraded to Buy: Here's Why - MSN

May 02, 2025
pulisher
May 02, 2025

GeneDx Holdings (WGS) Gets a Hold from Wells Fargo - The Globe and Mail

May 02, 2025
pulisher
May 01, 2025

GeneDx Holdings Corp. (WGS) Q1 Earnings and Revenues Surpass Estimates - MSN

May 01, 2025
pulisher
May 01, 2025

GeneDx price target lowered to $78 from $105 at Wells Fargo - TipRanks

May 01, 2025
pulisher
May 01, 2025

GeneDx Holdings (WGS) Receives Adjusted Price Target by Wells Fa - GuruFocus

May 01, 2025
pulisher
May 01, 2025

GeneDx price target lowered to $100 from $115 at BTIG - TipRanks

May 01, 2025
pulisher
May 01, 2025

GeneDx Holdings (WGS) Price Target Lowered by TD Securities | WG - GuruFocus

May 01, 2025
pulisher
May 01, 2025

GeneDx stock target cut to $100 by BTIG, maintains Buy rating - Investing.com Nigeria

May 01, 2025
pulisher
May 01, 2025

GeneDx Holdings (WGS) Receives Adjusted Price Target by Wells Fargo | WGS Stock News - GuruFocus

May 01, 2025
pulisher
May 01, 2025

GeneDx earnings selloff a buying opportunity, says Craig-Hallum - Yahoo Finance

May 01, 2025
pulisher
May 01, 2025

GeneDx (WGS) Price Target Reduced by TD Cowen Amid Strong Perfor - GuruFocus

May 01, 2025
pulisher
May 01, 2025

GeneDx (WGS) Price Target Reduced by TD Cowen Amid Strong Performance | WGS Stock News - GuruFocus

May 01, 2025
pulisher
May 01, 2025

GeneDx (WGS) Stock Decline Seen as Buying Opportunity | WGS Stoc - GuruFocus

May 01, 2025
pulisher
May 01, 2025

GeneDx Holdings Corp. (NASDAQ:WGS) Q1 2025 Earnings Call Transcript - Insider Monkey

May 01, 2025
pulisher
May 01, 2025

GeneDx (WGS) Sees Price Target Cut But Retains Buy Rating | WGS Stock News - GuruFocus

May 01, 2025
pulisher
May 01, 2025

Wells Fargo Adjusts Price Target for GeneDx (WGS) Amid Market Fl - GuruFocus

May 01, 2025

Genedx Holdings Corp Stock (WGS) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Genedx Holdings Corp Stock (WGS) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Meister Keith A.
Director
May 08 '25
Buy
56.01
100,000
5,600,994
3,008,629
PFENNIGER RICHARD C JR
Director
May 02 '25
Option Exercise
0.00
918
0
28,582
Feeley Kevin
CHIEF FINANCIAL OFFICER
Apr 29 '25
Option Exercise
0.00
753
0
3,725
Feeley Kevin
CHIEF FINANCIAL OFFICER
Apr 29 '25
Sale
113.09
388
43,879
3,337
Stueland Katherine
Chief Executive Officer
Apr 29 '25
Option Exercise
0.00
3,874
0
5,594
Stueland Katherine
Chief Executive Officer
Apr 29 '25
Sale
113.09
2,154
243,596
3,440
diagnostics_research DGX
$170.48
price down icon 4.35%
diagnostics_research LH
$241.34
price down icon 3.77%
$151.09
price down icon 2.23%
diagnostics_research WAT
$347.36
price down icon 4.07%
diagnostics_research MTD
$1,133.26
price down icon 4.45%
diagnostics_research IQV
$137.29
price down icon 5.28%
Cap:     |  Volume (24h):